Aquavit Pharmaceuticals Competitors and Similar CompaniesClear all

Aquavit Pharmaceuticals's competitors and similar companies include ASKA Pharmaceutical, Kanghong Pharmaceutical, Novopyxis and BL&H.

	Aquavit Pharmaceuticals Aquavit Pharmaceuticals is a multi-specialty healthcare company focused on discovering, developing, and commercializing pharmaceuticals, medical devices, and health technologies.	ASKA Pharmaceutical ASKA Pharmaceutical (あすか製薬株式会社) is a company that develops, manufactures, and sells pharmaceutical products.	Kanghong Pharmaceutical Kanghong Pharmaceutical (成都康弘药业集团股份有限公司) is a company that produces and sells biological products.	Novopyxis Novopyxis is a biotechnology company using mathematics and machine learning to engineer medical technology.	BL&H BL&H is a company developing and supplying drugs and medical devices.
Founding Date	Founding Date 2010	Founding Date 1920	Founding Date 1996	Founding Date 2013	Founding Date 1999
Type	Type Private	Type Subsidiary	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development medical devices medtech	Tags Healthcare drug development pharma veterinary	Tags Healthcare biotech drug development medical devices	Tags Healthcare biotech drug development medical devices medtech	Tags Healthcare biotech drug development medical devices medtech veterinary
Locations	Locations New York, US HQ Do, KR	Locations Tokyo, JP HQ Chiba, JP Fujisawa, JP Fukuoka, JP Hiroshima, JP Iwaki, JP Kanazawa, JP see more	Locations Cheng Du Shi, CN HQ	Locations HQ	Locations HQ
Employees	Employees 137% decrease	Employees 635	Employees 4,462	Employees 4	Employees N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥52.5b (FY, 2020)	Revenue (est.) ¥4.5b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ¥24.9b (FY, 2020)	Cost of goods ¥465.4m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ¥27.7b (FY, 2020)	Gross profit ¥4.1b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ¥649m (FY, 2020)	Net income ¥1.1b (FY, 2025)	Net income N/A	Net income N/A